Search results

Evidence-based recommendations on adalimumab (Humira), etanercept (Enbrel) and ustekinumab (Stelara) for plaque psoriasis in children and young people.

Result type

Technology appraisal guidance

Published

12 July 2017

This guideline covers assessing and managing psoriasis in adults, young people and children. It aims to improve long-term disease control and quality of life for people with psoriasis.

Result type

Clinical guideline

Last updated

1 September 2017

Recommendation ID TA455/1 Question Trials that evaluate utility values (using generic preference-based measures) in children and young

Result type

Research recommendation

Published

15 October 2018

TA455/1 | Trials that evaluate utility values (using generic preference-based measures)